Platinum Investment Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Platinum Investment Management’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-32,300	Closed	-$725K	–	91
2018 Q1	$725K	Hold	32,300	–	–	0.02%	77
2017 Q4	$972K	Hold	32,300	–	–	0.03%	67
2017 Q3	$1.22M	Hold	32,300	–	–	0.03%	61
2017 Q2	$900K	Hold	32,300	–	–	0.02%	63
2017 Q1	$1.11M	Sell	32,300 -6,000	-16%	-$212K	0.03%	63
2016 Q4	$1.1M	Hold	38,300	–	–	0.03%	61
2016 Q3	$1.22M	Hold	38,300	–	–	0.03%	65
2016 Q2	$1.24M	Sell	38,300 -7,700	-17%	-$258K	0.03%	61
2016 Q1	$1.29M	Buy	+46,000	New	+$1M	0.03%	63

Other funds holding ACAD

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return

First Trust Advisors

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return